Permax

Permax (pergolide) is a drug that was formerly prescribed in the United States to treat Parkinson's disease. Parkinson's in associated with low dopamine levels in the brain and this medication has some of the same effects on the body as dopamine.

The risk of heart valve damage attributed to Permax was shown to be much higher than was originally thought. One study showed that roughly one-fourth of Parkinson's patients taking pergolide had moderate to severe heart valve problems. Another study found that users of either drug were five to seven times more likely to have leaky heart valves than those on other types of Parkinson's medications.

Not only are these numbers staggering, but the issues caused by Permax are non-reversible and valve replacement surgery is the only solution. This medication seems to lead to adverse effects through the same heart-related mechanism that the fen-phen diet combination did.

About half a million people had taken Permax during its first 14 years on the market when its developer, Eli Lilly and Co., added valve damage to the potential side effects listed on the package insert in 2003. But the company said the risk was extremely low — five in 100,000 users.

About 1.5 million Americans and 6 million people worldwide have Parkinson's disease, which results in tremors, loss of muscle control and sometimes death.

If you or a loved one was prescribed Permax and experienced serious side effects, contact us today to determine if you may have a personal injury claim.

Category: 
  • Cylert (pemoline) was a drug used for attention deficit hyperactivity disorder for thirty years before it was discontinued.


    In some patients pemoline has been suspected of causing hepatotoxicity (liver toxicity), so the FDA recommended that regular liver tests should be performed on those treated with it.


    Despite attempted efforts to make doctors and patients aware of the risk, the drug has been linked with a number of cases of liver failure, of which 13 resulted in liver replacement or death.

  • Darvocet is a powerful painkiller that combined the opioid drug dextropropoxyphene with acetaminophen. It was removed from the market due to a variety of unforeseen side effects.


    One of the primary risks of Darvocet was the fact that it contained acetaminophen. Overdose of acetaminophen could happen all too easily, leading to potentially fatal liver toxicity.

  • Duragesis pain patches are a delivery method of the painkiller fentanyl that are able to provide up to three days' relief from severe chronic pain, such as that experienced by bone cancer patients. However, the active ingredient, as well as faulty construction of the patches themselves led to serious risks to patients and an FDA ban.


    Dozens of overdoses and deaths were linked to use of Duragesic patches before they were pulled from the market. An overdose of the morphine-like drug can put a patient into a coma and shut down breathing.

  • Eczema, also called atopic dermatitis is painful and troublesome form of skin inflammation. One major type of drug used to treat this condition is the topical immunosuppressant. This category of medication is applied to the skin of patients who do not respond to steroids.


    Two specific drugs, Elidel (pimecrolimus) and Protopic (tacrolimus), approved for treatment of eczema, are not without controversy. They have been closely associated with a possible cancer risk in studies done on animals.

  • Antidepressant drugs such as Effexor (venlafaxine) have been shown to increase the chance of suicidal thoughts and attempts in adults under age 25, while reducing the risk among older adults. Effexor is licensed for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder and social phobia.


    The risk of suicidal thinking or attempts is 62 percent higher among the young adults enrolled in clinical trials of antidepressants, compared with patients taking placebos, Food and Drug Administration staff has said. On the other hand, among adults over 25, the risk of suicidal thinking declines by 21 percent.

  • Enteryx is an injection used to treat gastroesophageal reflux disease (GERD). GERD is a chronic digestive disease where stomach acid flows back into the esophagus irritating its lining.


    Enteryx is injected as a liquid that solidifies into a spongy material that cannot be removed. When it is injected properly, it strengthens the lower esophagus, helping prevent stomach acid from entering it and causing pain.

  • Ephedra is an herbal stimulant that was used as a dietary supplement for both weight loss and athletic performance enhancement. However, it was linked to heart attacks, strokes and other health problems, which ultimately led to its ban by the Food and Drug Administration (FDA).


    Products containing ephedra and ephedra extract, also known as ma-huang, were widely promoted for losing weight and enhancing physical performance, with its popularity peaking in the early 2000s.

  • Letrozole is a drug approved for use only in postmenopausal women with breast cancer. But there is evidence some doctors have prescribed it as a fertility treatment because it suppresses estrogen and can promote ovulation. It is marketed under the name Femara.


    The manufacturer of a breast cancer drug, letrozole, has warned fertility doctors that it has been associated with birth defects, a caution prompted by reports that the drug was being used to help a woman become pregnant.


    Swiss drug manufacturer Novartis sent letters to fertility doctors worldwide to reiterate a warning that the drug should not be given to women who may be pregnant.

  • Fenfluramine/Phentermine, commonly called Fen-Phen, is a powerful diet drug that was taken by millions of Americans to combat obesity.


    However, clinical research showed that the fenfluramine portion of the combination can cause heart disease in otherwise healthy patients.


    Studies concluded that this drug could cause potentially fatal pulmonary hypertension and heart valve problems, which led to its eventually being pulled from the market.


    Though efforts were made to ensure that doctors no longer prescribed this harmful substance, many people were put at risk by this powerful drug.

  • Fosamax is an oral biphosphonate prescribed to millions of osteoporosis sufferers over the years. It is supposed to increase bone density by slowing down the body’s process of bone breakdown over time.


    However, researchers have now found that this drug can actually cause bones to weaken and crumble.